Searchable abstracts of presentations at key conferences in endocrinology

ea0090p10 | Adrenal and Cardiovascular Endocrinology | ECE2023

Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: A study of 709 cases

Brox Torrecilla Noemi , Garcia Cano Ana , Escobar-Morreale Hector F. , Valderrabano Pablo , Tobar Alejandra , Araujo-Castro Marta

Aim: To evaluate the prevalence and incidence of type 2 diabetes in patients with nonfunctioning adrenal incidentalomas (NFAI) and autonomous cortisol secretion (ACS) coming from a cohort of adrenal incidentalomas consecutively evaluated in a tertiary hospital in a predefined period (2013-2020).Methods: In this retrospective study, adrenal incidentalomas ≥1cm with ACS and NFAI were included. ACS was defined by a post-dexamethasone suppression test ...

ea0090p430 | Pituitary and Neuroendocrinology | ECE2023

Menin, p27 and pAKT role in prolactinoma development

Pena-Zanoni Milagros , Ines Abeledo-Machado Alejandra , Bornancini Dana , Marcial-Lopez Agustina , Rulli Susana , Diaz-Torga Graciela

Molecular mechanisms involved in lactotrophs cell proliferation that led to prolactinoma development are not fully understood. Cyclin-dependant kinase (CDK) p27Kip1 is a key cell cycle regulator, and it is regulated by Menin. The transgenic mice model MEN1+/-, as the p27 -/- knock-out mice, develop pituitary adenomas and other neuroendocrine tumours. Menin can also interfere with phosphorylated AKT (pAKT) function, known for i...

ea0037ep679 | Pituitary: basic and neuroendocrinology | ECE2015

Hyponatremia and mortality in patients hospitalised for heart failure (2005–2011)

Marco Javier , Crespo Irene , Ortola Ana , Gracia Teresa Ruiz , De Miguel Paz , Mendez Manuel , Nunez Karla , Lopez Judith , Duran Alejandra

Introduction: Hyponatremia is the most frequent electrolyte disorder in hospitalised patients. Our aim was to determine the incidence, mean hospital stay, readmission rate and mortality rate among patients with acute heart failure (HF) and hyponatremia.Methods: Retrospective analysis of data collected from the minimum data set (MDS) of Spanish National health System during 2005–2012 from discharged patients of Internal Medicine with HF and hyponatre...

ea0056gp154 | Obesity | ECE2018

Eating and substance-related disorders after bariatric surgery

Sanz Eva , Kinori Guila-Fidel , Parramon Gemma , Fidilio Enzamaria , Velasquez Mayra-Alejandra , Guerrero Mireia , Comas Marta , Mesa Jordi , Ciudin Andreea

Introduction: Obesity is a chronic condition with great morbidity, mortality and significant economic and psychosocial impact. Bariatric surgery has proven to be an effective therapy for sustained weight loss and has allowed a reduction in medical comorbidity and an improvement in self-esteem and life quality. However, recent evidence reports an increase in eating and substance-related disorders that are diagnosed in the postoperative period worsening the prognosis.<p clas...

ea0056p292 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial

Buendia Richard , Zambrano Monica , Buendia Andres , Vargas Tatiana , Morales Alejandra , Alejo Adriana , Cardenas Santiago , Mier Heidy , Sanchez Diego , Arrautt Johann

Background: Evidence has shown that the use of high doses of statins is associated with lower levels of LDL cholesterol and a decrease in cardiovascular events. Likewise, the use of high doses of statins may increase the risk of myopathy, elevation of liver enzymes, renal failure and cognitive alterations. We conducted a systematic review with a meta-analysis of all RCTs investigating the impact of atorvastatin and ezetimibe therapy on levels of LDL cholesterol vs high doses o...

ea0056p778 | Pituitary - Basic | ECE2018

Comparative differential effects of secretagogues upon regulation of pituitary GH in several vertebrates

Sosa Valeria Alejandra Urban , Mendoza Jose Avila , Salas Martha Carranza , Moreno Carlos Guillermo Martinez , Munoz Maricela Luna , Aramburo Carlos

It is known that the synthesis and release of pituitary GH is controlled by complex neuroendocrine mechanisms that involve several neuropeptides, such as GHRH, SST, PACAP, TRH, GnRH, Ghrelin, among other regulators. Previous reports indicate that, during vertebrate evolution, the potency and efficacy of these secretagogues may vary and play differential effects upon GH regulation. In this work we aimed to study, in vitro, the capacity of these peptides to control the ...

ea0093p15 | Guided Poster Tour 2: Miscellaneous | EYES2023

Metformin effect on retinal epithelial cells under different concentrations of glucose

Villa-Fernandez Elsa , Gomez Ana Victoria Garcia , Villarino Miguel Garcia , Fernandez-Fernandez Alejandra , Goitia Carmen Lambert , Delgado Elias

Background: Metformin is one of the first line drugs used to treat type 2 diabetes mellitus, even though there are still many gaps on how exactly metformin works. This is due to many years of research using various concentrations of metformin and also, not considering the conditional effect that glucose can have in its action.Objectives: Study the effect of different concentrations of metformin and glucose in cell culture.Methods: ...

ea0081ep841 | Pituitary and Neuroendocrinology | ECE2022

Descriptive study of the acromegaly disease activity according to ACRODAT® in a tertiary Hospital in Spain

Carlos Percovich Hualpa Juan , Anez Roberto , Centeno Rogelio Garci a , Fernandez Laura Gonzalez , Munoz Diego , Montenegro Alejandra Maricel Rivas , Fernandez Fernandez Elisa , Guerrero Crystal , Gonzalez Albarran Olga

Background: The goals of acromegaly treatment are to achieve long-term biochemical control, control tumor size and decrease the risk of developing systemic comorbidities. Moreover, from the patient’s perspective, symptoms and QoL are critical parameters of disease control and should be assessed routinely. To aid in the global clinical management of acromegaly, a holistic clinical decision support tool, the Acromegaly Disease Activity Tool (ACRODAT®) was developed.</p...

ea0090ep306 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Maturity Onset Diabetes of the Young (MODY) associated with mutations in the Regulatory factor X6 (RFX6) gene: A case report

Piorno Alberto Garcia , Gata Isabel Losada , Anez Roberto , Rivas Montenegro Alejandra Maricel , Gonzalez Gloria Collado , Hernanz Monica Gomez-Gordo , Albarran Olga Gonzalez

Introduction: Maturity onset diabetes mellitus of the young (MODY) is a form of monogenic diabetes characterized by pancreatic B-cell dysfunction. The most common subtypes are caused by mutations in the genes encoding glucokinase (GCK) and hepatocyte nuclear factor (HNF1a, HNF4a), although unidentified genes are also involved. Regulatory factor X6 (RFX6) is a transcription factor gene which has an important biological role in B-cell formation and function. Biallelic mutations ...

ea0065p198 | Metabolism and Obesity | SFEBES2019

Modulation of EGFR expression to increase islet transplantation success

Ali Usama , Suba Kinga , Bitsi Stavroula , Alonso Aldara Martin , Patel Yateen , Leclerc Isabelle , Rutter Guy A , Rothery Stephen , Salem Victoria , Tomas Alejandra

Background: Islet transplantation is an established treatment for type 1 diabetes mellitus. However, many recipients do not achieve independence from exogenous insulin since up to 50–70% of islets are lost post-transplant. An important factor determining transplant success is graft vascularisation. The epidermal growth factor receptor (EGFR) is a key pro-survival and proliferation factor. Here, we investigate for the first time if EGFR overexpression in pancreatic islets ...